Caused by pathogenic microorganisms, infectious diseases are known to cause high mortality rates, severe burdens of disability, and serious worldwide aftermaths. Drug-resistant pathogens have reduced the efficacy of available therapies against these diseases, thus accentuating the need to search for effective antimicrobials. Medicinal plants have served as starting material for the preparation of a number of antimicrobial agents. To this end, the present study highlights the green synthesis of Cocos nucifera-based nanomaterials and evaluation of the mechanistic basis of their antimicrobial action. Accordingly, Cocos nucifera extract was used for the reduction of silver nitrate solution to afford silver nanoparticles. These entities were further incorporated onto sulfuric-acid-based activated carbons to generate the nanocomposites. The antimicrobial activity of the as-prepared nanomaterials was evaluated using the broth microdilution method, while the antioxidant activity was assessed through standard methods. The cytotoxicity of potent nanomaterials was assessed on Vero cells by the spectrophotometric method. As a result, nanoparticles were successfully synthesized, as evidenced by the ultraviolet–visible spectroscopy analysis that revealed an intense absorption spectrum at 433 nm. Fourier Transform Infrared Spectroscopy presented the functional group moieties involved as a capping and reducing agent in the synthesis of the nanomaterials. The incubation of nanomaterials with selected bacterial and fungal strains has led to significant inhibitory effects of these pathogens with minimum inhibitory concentrations ranging from 7.813 to 250 μg/mL. In antioxidant assays, the nanocomposites presented scavenging activities comparable to those of ascorbic acid. Cytotoxicity experiment revealed no toxic effects on Vero cells (range of selectivity indices: from >4 to >128). These results provide evidence of the implication of Cocos nucifera-based nanomaterials in targeting bacterial or fungal systems that mediate free-radical damage or by inhibiting the oxidative damage caused by selected bacteria and fungi, the most susceptible being Escherichia coli and Candida albicans, respectively.

Plants belonging to the genus Irvingia are widespread across the African and Southeast Asian regions of the world. Irvingia gabonensis, Irvingia malayana, and Irvingia grandifolia are among the commonly used species in ethnomedicine, especially in Africa. Fever, scabies, toothache, inflammation, and liver and gastrointestinal disorders are among the pathological conditions that are reverted by Irvingia plants upon traditional preparations. Modern pharmacological investigations have substantiated the ethnomedicinal uses of Irvingia spp. Reports on the phytochemical analysis of Irvingia plants have revealed the presence of a number of secondary metabolites such as flavonoids, phenolic compounds, tannins, saponins, and alkaloids. Based on the foregoing, the present study provides a comprehensive evaluation of reports on the ethnomedicinal use, phytochemistry, pharmacology, and toxicity of plants from the genus Irvingia. Relevant information on Irvingia plants was mostly obtained from major scientific databases from their inception until July 2023. As a result, more than forty compounds have been identified in Irvingia spp., proving the abundance of secondary metabolites in these plants. Reports have pointed out modern pharmacological activities such as antiprotozoal, antimicrobial, antioxidant, antidiabetic, anti-inflammatory, and hepatoprotective activities. The present study provides more insights for the successful utilization of Irvingia plants and may guide further research on their therapeutic potential in the treatment of various diseases.

Shigellosis is a pathological condition that affects the digestive system and possibly causes diarrhoea. Shigella species, which are responsible for this disease, are highly contagious and spread through contaminated food and water. The increasing development of resistance by Shigella species necessitates the urgent need to search for new therapies against diarrhoea-causing shigellosis. The scientific validation of medicinal plants, such as Diospyros gilletii, which is used for the traditional treatment of diarrhoeal conditions is worthwhile. The present study aims to investigate the antibacterial activity of extracts from D. gilletii against selected Shigella species. Extracts from D. gilletii stem bark were prepared by maceration using various solvents. The antibacterial activity of D. gilletii extracts was evaluated in Shigella dysenteriae, S. flexneri, S. boydii, and S. sonnei using a microdilution method, whereas a cytotoxicity test was performed on Vero and Raw cells using resazurin-based colorimetric assays. Bacterial membrane-permeability studies were evaluated using propidium iodide (PI)- and 1-N-phenyl-naphthylamine (NPN)-uptake assays, whereas inhibition and eradication tests on bacterial biofilms were carried out by spectrophotometry. As a result, methanol, ethanol and hydroethanol (water: ethanol; 30:70, v/v) extracts of D. gilletii inhibited the growth of S. boydii, S. flexneri and S. sonnei, with minimum inhibitory concentration (MIC) values ranging from 125 to 500 µg/mL, without toxicity to Vero and Raw cells. Time-kill kinetics revealed bactericidal orientation at 2 MIC and 4 MIC and a bacteriostatic outcome at 1/2 MIC. The mechanistic basis of antibacterial action revealed that D. gilletii extracts inhibited and eradicated Shigella biofilms and promoted the accumulation of NPN and PI within the inner and outer membranes of bacteria to increase membrane permeability, thereby causing membrane damage. This novel contribution toward the antibacterial mechanisms of action of D. gilletii extracts against Shigella species substantiates the use of this plant in the traditional treatment of infectious diarrhoea.

Background: Different parts of Allanblackia floribunda, Calotropis procera, Hymenocardia acida, Irvingia gabonensis, Newbouldia laevis, and Xylopia acutiflora have been used traditionally across different parts of Cameroon to overcome infectious diseases, especially pneumonia. Hence, this study investigated the antibacterial potential of six Cameroonian medicinal plants against selected ESKAPE pathogens (Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Escherichia coli, Pseudomonas aeruginosa) as well as Streptococcus pneumoniae. Methodology: The inhibitory activities of different extracts from six Cameroonian plants against the pathogens were evaluated by determining their MICs. Subsequently, the top four bioactive plant extracts were assessed for antibiofilm activity, time-kill kinetics, cytotoxicity (Raw and Vero cell lines), as well as antioxidant activities. Finally, the effect of the most potent extract, viz. ethanolic extract of Xylopia acutiflora steam bark, on bacterial morphology was elucidated through scanning electron microscopy while its phytochemical composition was profiled using liquid chromatography–mass spectrometry (LC–MS). Results: Twenty-two out of the 32 prepared extracts showed significant antibacterial activity, with MICs varying from 31.5 to 1000 µg/mL. The ethanolic, methanolic, and hydroethanolic extracts from Xylopia acutifolia and ethanolic extract from Colotropix procera exhibited broad-spectrum activity, inhibiting and eradicating bacterial biofilm. Furthermore, the extract from X. acutifolia was shown to be the most effective scavenger against DPPH (IC₅₀; 83.79 ± 1.92 µg/mL) and FRAP (IC₅₀; 22.89 ± 1.36 µg/mL) radicals, while C. procera extract was the most effective against ABTS (IC₅₀; 67.95 ± 1.83 µg/mL). The extracts were demonstrated to possess low cytotoxicity on both Raw and Vero cell lines. In addition, SEM revealed that X. acutifolia elicited cell membrane rupture and consequently cytoplasm leakage in E. coli and P. aeruginosa. Twenty-four different compounds were detected in the X. acutifolia extract via LC–MS analysis, and it was hypothesized that the recorded bioactivity in the extract might be ascribed to these compounds. Conclusion: Results from this study have scientifically validated the ethnomedicinal uses of the six Cameroonian plants as therapeutics for infections with X. acutiflora ethanolic extract displaying the highest bioactivity. Thus, there is the need for further investigations into phytochemicals from these plants as they could serve as important sources of novel antioxidants and antimicrobial agents. Graphical